A PHASE I STUDY OF FLAVOPIRIDOL (NSC# 649890; IND# 46211) IN PATIENTS WITH RELAPSED OR REFRACTORY PEDIATRIC SOLID TUMORS OR LYMPHOMAS
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2013
At a glance
- Drugs Alvocidib (Primary)
- Indications CNS cancer; Ewing's sarcoma; Lymphoma; Neuroblastoma; Osteosarcoma; Rhabdomyosarcoma; Solid tumours; Wilms' tumour
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Oct 2009 New source identified and integrated (New Jersey Cancer Trial Connect; COG-ADVL0017)
- 18 Sep 2005 New trial record.